Evidence map›Paper›PMID 37576992›Full record

ArticleFrontiers in bioengineering and biotechnology2023

Tailoring mSiO

Xinqiang Liang, Wenting Xu, Siyi Li, Mekhrdod S Kurboniyon, Kunying Huang, Guilan Xu, Wene Wei, Shufang Ning, Litu Zhang, Chen Wang

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Advances in magnetic induction hyperthermia.Frontiers in bioengineering and biotechnology · 2024
    Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Xinqiang LiangDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Wenting XuDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Siyi LiCollege of Material Sciences and Chemical Engineering, Harbin Engineering University, Harbin, China.
Mekhrdod S KurboniyonNational Academy of Sciences of Tajikistan, Dushanbe, Tajikistan.
Kunying HuangDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Guilan XuDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Wene WeiDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Shufang NingDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Litu ZhangDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Chen WangDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Guangxi Medical University · CNAcademy of Sciences of the Republic of Tajikistan · TJHarbin Engineering University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperthermia therapy is a hotspot because of its minimally invasive treatment process and strong targeting effect. Herein, a synergistic magnetic and photothermal therapeutic nanoplatform is rationally constructed. The well-dispersive mSiO

Indexed as

magnetic effectmSiO2permanent magnetphotothermal effecttumor therapy

Identifiers

PMID37576992
PMCPMC10413386
OpenAlexW4385302327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.